Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

BJUI compass

Showing results (481-490 of 645) with videos related to

Pageof 65
Sort By:
BJUI Compass|September 16, 2025
Step-by-step: A traction-based fenestration method for vasoepididymostomyKosuke Kojo, Masahiro Uchida, Kazumitsu Yamasaki, et al.
BJUI Compass|June 5, 2020
Decreasing postoperative opioid use while managing pain: A prospective study of men who underwent scrotal surgeryAubrey B Greer, Libert Ramos, Justin M Dubin, et al.
BJUI Compass|October 21, 2022
What's in a tweet? Optimizing social media impressionsRalph Grauer, Dallin Busby, Emily Neckonoff, et al.
BJUI Compass|April 27, 2022
The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients-First European DataNikhil Vasdev, Alexander Hampson, Samita Agarwal, et al.
BJUI Compass|April 27, 2022
The great escape: A tale of the visiting professor's Artful DodgeJohn W Davis
BJUI Compass|April 27, 2022
Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium-223Yasuhide Miyoshi, Sohgo Tsutsumi, Takashi Kawahara, et al.
BJUI Compass|April 27, 2022
The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian settingJia Ying Isaac Tay, Ken Chow, Dominic J Gavin, et al.
BJUI Compass|April 27, 2022
Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstructionBrian S H Ho, Peter K F Chiu, Wayne Lam, et al.
BJUI Compass|April 27, 2022
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinomaYoshiharu Okuyama, Shingo Hatakeyama, Kazuyuki Numakura, et al.
BJUI Compass|April 27, 2022
Eye of the beholder-Tales from Prostate Cancer Active Surveillance DevelopmentJohn W Davis
Pageof 65

Showing results (481-490 of 645) with videos related to

Sort By:
Pageof 65
BJUI Compass|September 16, 2025
Step-by-step: A traction-based fenestration method for vasoepididymostomyKosuke Kojo, Masahiro Uchida, Kazumitsu Yamasaki, et al.
BJUI Compass|June 5, 2020
Decreasing postoperative opioid use while managing pain: A prospective study of men who underwent scrotal surgeryAubrey B Greer, Libert Ramos, Justin M Dubin, et al.
BJUI Compass|October 21, 2022
What's in a tweet? Optimizing social media impressionsRalph Grauer, Dallin Busby, Emily Neckonoff, et al.
BJUI Compass|April 27, 2022
The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients-First European DataNikhil Vasdev, Alexander Hampson, Samita Agarwal, et al.
BJUI Compass|April 27, 2022
The great escape: A tale of the visiting professor's Artful DodgeJohn W Davis
BJUI Compass|April 27, 2022
Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium-223Yasuhide Miyoshi, Sohgo Tsutsumi, Takashi Kawahara, et al.
BJUI Compass|April 27, 2022
The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian settingJia Ying Isaac Tay, Ken Chow, Dominic J Gavin, et al.
BJUI Compass|April 27, 2022
Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstructionBrian S H Ho, Peter K F Chiu, Wayne Lam, et al.
BJUI Compass|April 27, 2022
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinomaYoshiharu Okuyama, Shingo Hatakeyama, Kazuyuki Numakura, et al.
BJUI Compass|April 27, 2022
Eye of the beholder-Tales from Prostate Cancer Active Surveillance DevelopmentJohn W Davis
Pageof 65